Thank you, Mr. Chair. Thank you to our panel of witnesses today. This is one of the better panels that we have constructed here, I think.
I have a few questions. First, in thinking about R and D models, university-led research, which is effectively the model in North America, Canada and the United States, hasn't produced major innovative technologies in terms of commercialization that bring revenue back for its use. I'm thinking of warfarin, which is a blood thinner, Gatorade, and voice-activated calling. Of the three, that's the most recent in terms of technology. The other two, of course, are decades old.
Look at the Fraunhofer model in Germany, for example, where for 30¢ on the dollar of government investment, the model has produced everything from MP3 compression algorithms to video compression; triple junction solar cells, which I think still hold the world record for solar energy conversion efficiency; E-Puzzler, which is a system, if you will, that will allow you to repiece shredded documents; and a number of other technologies that are all much more recently converted and that are commercialized into revenue streams in the hundreds of millions of dollars, cumulatively.
Do we have the wrong model in Canada for research and development as it relates to involvement with businesses?